title: [Factor XIII deficiency in adults with acute leukemia: results of a substitution therapy with factor XIII (author's transl)].
abstract: A decrease in fibrin stabilizing factor (Factor XIII) is the most frequent coagulation disorder seen in adults with acute leukemia. Patients with prominent reduction of factor XIII (FSF) (less than 50%) were substituted with a factor XIII concentrate from human placenta, and factor XIII plasma concentration and bleeding tendency were followed up during the course of the disease. After substitution plasma, factor XIII activity went up to normal levels in most of the patients. As compared to the course of 12 patients with distinct factor XIII reduction without factor XIII therapy, there were less bleeding complications in 13 courses of patients with prominent reduction of factor XIII substituted with factor XIII concentrate and in 11 with normal or only slightly reduced factor XIII levels.
mesh_terms: D000208:Acute Disease; D005176:Factor XIII / Q000627:therapeutic use*; D005177:Factor XIII Deficiency / Q000150:complications* / Q000188:drug therapy / Q000209:etiology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000150:complications*; D007948:Leukemia, Monocytic, Acute / Q000150:complications; D015470:Leukemia, Myeloid, Acute / Q000150:complications
chemical_list: D006493:Heparin; D005176:Factor XIII
references.citation: Blut. 1974 Feb;28(2):81-90
references.pmid: 4812252
references.citation: Blood. 1972 Nov;40(5):709-18
references.pmid: 5078928
references.citation: Blood. 1964 Jun;23:717-28
references.pmid: 14161406
references.citation: Thromb Res. 1975 Apr;6(4):315-29
references.pmid: 1079636
references.citation: Anal Biochem. 1966 Apr;15(1):45-52
references.pmid: 5959431
references.citation: Blood. 1973 Apr;41(4):599-603
references.pmid: 4688874
references.citation: Helv Med Acta. 1967 Dec;34(1):44-53
references.pmid: 5242897
references.citation: Blood. 1977 Feb;49(2):219-31
references.pmid: 299817
references.citation: Scand J Haematol Suppl. 1971;13:317-22
references.pmid: 4945833
references.citation: Klin Wochenschr. 1974 Mar 1;52(5):233-7
references.pmid: 4835639
references.citation: Acta Haematol. 1970;43(2):65-72
references.pmid: 4986192
references.citation: Klin Wochenschr. 1972 Nov 1;50(21):1017-9
references.pmid: 4508631
references.citation: Acta Haematol. 1972;48(6):322-30
references.pmid: 4633099
references.citation: Verh Dtsch Ges Inn Med. 1971;77:97-100
references.pmid: 5155938
references.citation: J Clin Invest. 1975 Jul;56(1):30-8
references.pmid: 237938
references.citation: Dtsch Med Wochenschr. 1971 Apr 23;96(17):715-27 passim
references.pmid: 5279887
references.citation: Thromb Diath Haemorrh Suppl. 1969;36:215-31
references.pmid: 4915827
references.citation: Hoppe Seylers Z Physiol Chem. 1974 Sep;355(9):1077-82
references.pmid: 4461651
references.citation: Blood. 1964 May;23:669-78
references.pmid: 14142505
references.citation: Blut. 1975 Mar;30(3):153-62
references.pmid: 1122339
vernacular_title: Faktor XIII-Mangel bei akuter Leukämie des Erwachsenen: Ergebnisse einer Substitution mit Faktor XIII.